Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson to Discuss Intent to Separate Consumer Health Business Call Transcript

Nov 12, 2021 / 01:30PM GMT
Release Date Price: €144.08 (+1.54%)
Operator

Hello, and welcome to the Johnson & Johnson investor update conference call and webcast. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the conference over to Executive Vice President and Chief Financial Officer, Joe Wolk. Please go ahead, sir.

Joseph J. Wolk
Johnson & Johnson - Executive VP & CFO

Thank you, Kevin, and welcome, everyone. This is Joe Wolk, Chief Financial Officer of Johnson & Johnson. We appreciate everyone joining us on such short notice this morning. On the call with me today are Alex Gorsky, Chairman and Chief Executive Officer; and Joaquin Duato, Vice Chairman of the Executive Committee and incoming Chief Executive Officer.

This call is being made available via webcast, accessible through the Investor Relations section of the Johnson & Johnson website at investor.jnj.com. There, you can find additional materials, including the slides that will accompany this call.

Please note that today's presentation includes forward-looking statements. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot